check_circleStudy Completed
Magnetic Resonance Imaging, Liver Neoplasms
Bayer Identifier:
90932
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
MRI study of Gadovist (1.0 M ) and Magnevist with a single i.v. injection in patients with known or suspected liver lesions
Trial purpose
Please see attached Study Results Summary below.
Key Participants Requirements
Sex
N/AAge
N/ATrial summary
Enrollment Goal
572Trial Dates
July 2001 - August 2002Phase
Phase 3Could I Receive a placebo
N/AProducts
Gadavist/Gadovist (Gadobutrol, BAY86-4875)Accepts Healthy Volunteer
N/APrimary Outcome
Secondary Outcome
Trial design
Trial Type
InterventionalIntervention Type
N/ATrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A